Toxicological Evaluation in Pediatric Drug Development lssues to Consider Regarding Pediatric Drug Development : How to Ensure Safety Evaluation of Pediatric Drug Products in Non-clinical Safety Studies(Breaking Through the Stage of Non-clinical to Clinic

スポンサーリンク

概要

• 論文の詳細を見る
• 日本トキシコロジー学会の論文
• 2005-10-31

著者

• HORII Ikuo

  Pfizer Global Research & Development, Nagoya Laboratories, Pfizer Inc.

• Horii Ikuo

  Pfizer Global Research And Development Worldwide Safety Sciences

関連論文

• EFFECT OF DOSE REGIMEN ON THE TOXICITY OF 2'-DEOXY-2'-METHYLIDENECYTIDINE (DMDC) IN MONKEYS
• RELATIONSHIP BETWEEN AUC of 5'-DFUR AND TOXICITY OF CAPECITABINE, FLUOROPYRIMIDINE CARBAMATE ANALOGS, AND 5'-DFUR IN MONKEYS, MICE, AND RATS
• Current Status and Future Aspects of Toxicological Biomarkers in Safety Evaluation(EDUCATIONAL LECTURES, Proceedings of the 32nd Annual Meeting)
• Toxicologist Certification and IART (International Assembly for the Recognition of Toxicologists)(Qualification test system and international situation, Proceedings of the 32nd Annual Meeting)
• Toxicological Evaluation in Pediatric Drug Development lssues to Consider Regarding Pediatric Drug Development : How to Ensure Safety Evaluation of Pediatric Drug Products in Non-clinical Safety Studies(Breaking Through the Stage of Non-clinical to Clinic
• The use of gene expression profiling in rat hepatocyte cultures using adapter-tagged competitive PCR (TOXICOGENOMICS AND TOXICOPROTEOMICS) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
• Molecular Toxicological Approach in Drug Discovery and Development(WORKSHOP 3 : TOXICOGENOMICS AND MOLECULAR TOXICOLOGY)

スポンサーリンク